PPARG and fatty liver disease: Studies in rodents suggest that activation of hepatic PPARγ signaling promotes lipid accumulation in the liver [102], and hepatic expression of PPARγ is elevated in rodent models of diabetes and insulin resistance that exhibit liver steatosis.